Hecht, MD, discusses the phase 3 OrigAMI-3 trial for patients with recurrent, unresectable, or metastatic RAS/BRAF wild-type colorectal cancer.

Researchers have discovered that plant-derived phytochemicals and their gut microbiome metabolites control the effectiveness ...

Data shows adding durvalumab (Imfinzi) to the standard chemotherapy combination known as FLOT before and after surgery kept ...

Patients with colon cancer who consumed an anti-inflammatory diet during a phase 3 clinical trial showed longer overall ...

A combination drug treatment doubled survival time for patients with an aggressive form of colorectal cancer, according to ...

Dual MAPK inhibition (dMAPKi) as an effective therapeutic strategy for class II BRAF mutant (mt) metastatic melanoma (MM). This is an ASCO Meeting Abstract from the 2018 ASCO Annual Meeting I. This ...

A new report by FutureWise Research highlights a powerful trend in modern medicine: as awareness and innovation rise, hope ...

CONTEXT: Gastrointestinal stromal tumor (GIST) is the most common mesenchymal tumor. Cellular proliferation and apoptosis is gaining importance for predicting prognosis in several cancers. OBJECTIVE: ...

The best way to decrease your risk of serious cancer is to get tested for it. Because colon and rectum are both parts of the large intestine, screening for cancer in these areas is similar. These ...

In 1997, a Johns Hopkins research team found an inherited genetic mutation called APC I1307K. Adenomatous polyposis coli (APC) is a gene that suppresses tumor growth. If the APC gene is defective, it ...

The classification and nomenclature are not well established and knowledge acquired in neuroendocrine neoplasms of lungs and certain gastrointestinal sites ... ("neuroendocrine" [All Fields] OR ...